In patients with stable chronic coronary disease, how effective is colchicine in preventing cardiovascular events and what are the adverse reactions when compared to placebo?
| Errataetall: |
CommentOn: Rev Med Interne. 2020 Mar;41(3):218-219. - PMID 32037255 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
La Revue de medecine interne - 41(2020), 12 vom: 03. Dez., Seite 862-863 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Chez les patients avec maladie coronarienne athérosclérotique chronique stable, quelle est l’efficacité de la colchicine pour prévenir les événements cardiovasculaires et son innocuité comparativement au placebo ? |
|---|
| Beteiligte Personen: |
Lanthier, L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.01.2021 Date Revised 14.01.2021 published: Print-Electronic CommentOn: Rev Med Interne. 2020 Mar;41(3):218-219. - PMID 32037255 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.revmed.2020.10.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317360892 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317360892 | ||
| 003 | DE-627 | ||
| 005 | 20231225163113.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.revmed.2020.10.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1057.xml |
| 035 | |a (DE-627)NLM317360892 | ||
| 035 | |a (NLM)33168351 | ||
| 035 | |a (PII)S0248-8663(20)30379-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Lanthier, L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In patients with stable chronic coronary disease, how effective is colchicine in preventing cardiovascular events and what are the adverse reactions when compared to placebo? |
| 246 | 3 | 3 | |a Chez les patients avec maladie coronarienne athérosclérotique chronique stable, quelle est l’efficacité de la colchicine pour prévenir les événements cardiovasculaires et son innocuité comparativement au placebo ? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.01.2021 | ||
| 500 | |a Date Revised 14.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Rev Med Interne. 2020 Mar;41(3):218-219. - PMID 32037255 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Colchicine |2 NLM | |
| 650 | 7 | |a SML2Y3J35T |2 NLM | |
| 700 | 1 | |a Dussault, C |e verfasserin |4 aut | |
| 700 | 1 | |a Huard, G |e verfasserin |4 aut | |
| 700 | 1 | |a Plourde, M-E |e verfasserin |4 aut | |
| 700 | 1 | |a Cauchon, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t La Revue de medecine interne |d 1983 |g 41(2020), 12 vom: 03. Dez., Seite 862-863 |w (DE-627)NLM012660108 |x 1768-3122 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2020 |g number:12 |g day:03 |g month:12 |g pages:862-863 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.revmed.2020.10.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2020 |e 12 |b 03 |c 12 |h 862-863 | ||